Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 946 AL 960

Involvement of aquaporin 4 in astrocyte function and neuropsychiatric disorders

Xiao M, Hu G.

CNS Neurosci Ther. 2014 May;20(5):385-90. doi: 10.1111/cns.12267. Epub 2014 Apr 8.

Parkinson's disease and risk of fracture: a meta-analysis of prospective cohort studies

Tan L, Wang Y, Zhou L, Shi Y, Zhang F, Liu L, Nie S.

PLoS One. 2014 Apr 8;9(4):e94379. doi: 10.1371/journal.pone.0094379. eCollection 2014.

Dysautonomia in Parkinson disease

Goldstein DS.

Compr Physiol. 2014 Apr;4(2):805-26. doi: 10.1002/cphy.c130026.

Can Isolated Enlarged Virchow-Robin Spaces Influence the Clinical Manifestations of Parkinson's Disease?

Mestre TA, Armstrong MJ, Walsh R, Al Dakheel A, Moro E, Stoessl AJ, Lang AE.

Mov Disord Clin Pract. 2014 Apr 10;1(1):67-69. doi: 10.1002/mdc3.12009. eCollection 2014 Apr.

Advances in the Genetics of Parkinson's Disease: A Guide for the Clinician

Sheerin UM, Houlden H, Wood NW.

Mov Disord Clin Pract. 2014 Apr 10;1(1):3-13. doi: 10.1002/mdc3.12000. eCollection 2014 Apr.

System-based approaches to decode the molecular links in Parkinson's disease and diabetes

Santiago JA, Potashkin JA.

Neurobiol Dis. 2014 Dec;72 Pt A:84-91. doi: 10.1016/j.nbd.2014.03.019. Epub 2014 Apr 6.

Prevalence of malnutrition in patients with Parkinson's disease: a comparative study with healthy controls using Mini Nutritional Assessment (MNA) questionnaire

Fereshtehnejad SM, Ghazi L, Sadeghi M, Khaefpanah D, Shahidi GA, Delbari A, Lökk J.

J Parkinsons Dis. 2014;4(3):473-81. doi: 10.3233/JPD-130323.

Predicting the development of levodopa-induced dyskinesias: a presynaptic mechanism?

Lewitt PA, Mouradian MM.

Neurology. 2014 May 6;82(18):1574-5. doi: 10.1212/WNL.0000000000000390. Epub 2014 Apr 9.

Changes in mitochondrial function are pivotal in neurodegenerative and psychiatric disorders: how important is BDNF?

Markham A, Bains R, Franklin P, Spedding M.

Br J Pharmacol. 2014 Apr;171(8):2206-29. doi: 10.1111/bph.12531.

[Comparison of clinical symptoms for Uygur and Han Parkinson's disease patients]

Shang Y, Zhang X, Li Y, Liu Y, Li Y, Xiao Y, Han X, Guo M, Fei L.

Zhonghua Yi Xue Za Zhi. 2014 Jan 7;94(1):31-5.

Perioperative implications of the patient with autonomic dysfunction

McGrane S, Atria NP, Barwise JA.

Curr Opin Anaesthesiol. 2014 Jun;27(3):365-70. doi: 10.1097/ACO.0000000000000072.

Effect of rivastigmine on mobility of patients with higher-level gait disorder: a pilot exploratory study

Gurevich T, Balash Y, Merims D, Peretz C, Herman T, Hausdorff JM, Giladi N.

Drugs R D. 2014 Jun;14(2):57-62. doi: 10.1007/s40268-014-0038-8.

[Challenges in the pharmacotherapeutic management of the hospitalised patient with Parkinson's disease]

Lertxundi U, Domingo-Echaburu S, Irigoyen I, Isla A, Solinís MÁ, García-Moncó JC.

Rev Neurol. 2014 Apr 16;58(8):353-64.

Harnessing neurogenesis for the possible treatment of Parkinson's disease

Lamm O, Ganz J, Melamed E, Offen D.

J Comp Neurol. 2014 Aug 15;522(12):2817-30. doi: 10.1002/cne.23607. Epub 2014 May 9.

Interneurons from embryonic development to cell-based therapy

Southwell DG, Nicholas CR, Basbaum AI, Stryker MP, Kriegstein AR, Rubenstein JL, Alvarez-Buylla A.

Science. 2014 Apr 11;344(6180):1240622. doi: 10.1126/science.1240622.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias